corticosteroid
use
treat
infecti
diseas
year
although
shown
highli
effect
improv
clinic
cours
diseas
effect
clearli
defin
other
nevertheless
still
use
consider
number
physician
review
analys
role
system
corticosteroid
treatment
acut
pharyng
ap
communityacquir
pneumonia
cap
acut
otiti
media
aom
number
trial
involv
patient
ap
carri
mar
methodolog
flaw
allow
firm
conclus
drawn
number
trial
involv
cap
patient
even
higher
data
suggest
corticosteroid
may
reduc
risk
death
patient
sever
diseas
data
concern
aom
current
reason
prescrib
corticosteroid
treat
overal
data
show
current
indic
univers
use
system
corticosteroid
review
diseas
highqual
studi
respiratori
tract
infect
need
order
identifi
patient
prescript
corticosteroid
ration
accept
attempt
use
corticosteroid
infecti
diseas
made
year
earli
report
relat
typhoid
fever
tubercul
mening
bacteri
sepsi
clearli
suggest
could
significantli
improv
clinic
cours
sever
infect
led
widespread
use
corticosteroid
number
infecti
diseas
howev
subsequ
find
may
sometim
ineffect
harm
due
immunosuppress
potenti
neg
effect
convinc
mani
clinician
avoid
univers
use
limit
prescript
clinic
condit
indisput
data
concern
efficaci
safeti
toler
corticosteroid
significantli
downregul
inflammatori
respons
inhibit
migrat
polymorphonuclear
leukocyt
blood
vessel
affect
gene
regul
way
reduc
transcript
wide
rang
proinflammatori
cytokin
chemokin
adhes
molecul
cellular
inflammatori
receptor
also
reduc
express
number
proinflammatori
enzym
nitric
oxid
synthas
cyclooxygenas
phospholipas
consequ
reduc
inflammatori
product
ie
nitric
oxid
prostaglandin
leukotrien
gener
inflamm
benefit
host
infecti
diseas
use
elimin
infect
pathogen
howev
excess
amplif
inflammatori
respons
may
worsen
clinic
cours
infecti
diseas
lead
signific
tissu
damag
develop
system
effect
indic
corticosteroid
use
infecti
diseas
inflamm
particularli
sever
danger
activ
inflammatori
process
remain
within
normal
rang
mcgee
hirschmann
recent
review
publish
studi
regard
use
corticosteroid
infecti
diseas
divid
effect
five
possibl
outcom
base
degre
improv
clinic
cours
diseas
effect
lack
clear
data
concern
real
efficaci
demonstr
neg
impact
review
confirm
posit
effect
corticosteroid
infecti
diseas
especi
particularli
sever
associ
signific
risk
death
patient
herp
zoster
receiv
greatest
benefit
experienc
pain
true
patient
pneumocysti
jirovecii
pneumonia
hypoxaemia
similarli
surviv
advantag
greatest
patient
diseas
characteris
highest
baselin
mortal
rate
tubercul
mening
pericard
typhoid
fever
howev
although
posit
exampl
meant
prescript
corticosteroid
came
consid
mandatori
treatment
diseas
role
fulli
defin
infecti
condit
said
whether
realli
increas
impact
standard
therapi
whether
possibl
advantag
outweigh
potenti
harm
caus
acut
pharyng
ap
communityacquir
pneumonia
cap
acut
otiti
media
aom
particularli
children
common
infecti
diseas
time
diseas
system
corticosteroid
wide
prescrib
itali
countri
mainli
southern
europ
although
codifi
offici
guidelin
defin
real
clinic
relev
treatment
ap
cap
aom
seem
import
order
avoid
clinic
econom
problem
case
inefficaci
increas
cure
rate
case
posit
effect
aim
review
assess
whether
enough
reason
use
system
corticosteroid
diseas
whether
studi
need
clinic
trial
concern
use
corticosteroid
adult
children
last
year
select
pubm
medlin
use
combin
text
word
thesauru
term
appropri
concept
ap
cap
aom
relat
metaanalys
use
evalu
characterist
qualiti
select
studi
ap
common
children
adult
former
caus
medic
visit
latter
account
outpati
visit
case
ap
due
virus
mainli
rhinoviru
coronaviru
adenoviru
wherea
streptococcu
pyogen
mycoplasma
pneumonia
frequent
encount
bacteri
pathogen
pyogen
account
case
children
adult
mainli
difficulti
identifi
pathogen
respiratori
secret
aetiolog
role
pneumonia
precis
defin
clinic
relev
viral
pharyng
margin
case
spontan
resolv
day
without
produc
signific
sequela
wherea
case
caus
pyogen
follow
sever
earli
late
complic
peritonsillar
abscess
cervic
lymphaden
mastoid
glomerulonephr
rheumat
fever
explain
intern
guidelin
produc
scientif
societi
recommend
use
antibiot
streptococc
aetiolog
demonstr
strongli
suspect
although
differ
patient
select
pneumonia
consid
danger
pathogen
expert
therefor
usual
sought
consequ
remain
untreat
although
data
seem
suggest
caus
recurr
involv
upper
lower
respiratori
tract
regardless
aetiolog
ap
usual
accompani
fever
signific
sore
throat
antipyret
analges
effect
paracetamol
ibuprofen
recommend
even
streptococc
case
antibiot
slight
benefici
effect
reduc
symptom
fever
corticosteroid
inhibit
transcript
proinflammatori
mediat
human
airway
endotheli
cell
caus
pharyng
inflamm
ultim
symptom
pain
may
benefici
upper
respiratori
tract
infect
acut
rhinosinus
consequ
suggest
could
offer
similar
symptomat
relief
sore
throat
could
use
treatment
ap
number
clinic
trial
evalu
effect
corticosteroid
administr
combin
antibiot
patient
ap
tabl
summaris
main
clinic
characterist
studi
case
studi
shown
corticosteroid
benefici
patient
ap
comparison
placebo
treatment
associ
significantli
faster
reduct
pain
complet
pain
relief
led
author
suggest
univers
use
corticosteroid
treatment
ap
systemat
review
metaanalys
shown
definit
conclus
drawn
studi
methodolog
weak
way
assess
drug
efficaci
other
adequ
consid
import
characterist
enrol
patient
corticosteroid
administr
may
influenc
result
moreov
advantag
corticosteroid
use
ie
reduct
durat
pain
without
chang
number
lost
school
work
day
deem
modest
justifi
univers
administr
ap
methodolog
limit
evalu
effect
corticosteroid
highlight
way
mean
time
onset
pain
relief
complet
resolut
pain
report
inadequ
method
evalu
standard
deviat
use
graphic
represent
alon
could
led
difficult
frequent
inaccur
analys
collect
data
moreov
particularli
younger
children
mean
time
onset
pain
relief
pain
resolut
would
limit
recal
bia
strictli
depend
patient
memori
attent
problem
togeth
record
method
final
differ
efficaci
visual
method
use
objectifi
pain
particularli
children
trial
conduct
emerg
depart
set
suggest
studi
particularli
carri
geograph
area
difficult
reach
hospit
least
part
enrol
patient
could
sever
throat
pain
result
may
appli
primari
care
studi
enrol
fewer
patient
exud
sore
throat
ie
milder
baselin
symptom
show
signific
chang
time
onset
pain
relief
hayward
et
al
found
effect
corticosteroid
mean
time
onset
pain
relief
homogen
sever
exud
bacteriaposit
sore
throat
furthermor
studi
includ
children
adult
analys
pool
data
could
lead
wrong
conclus
metaregress
analysi
data
regard
children
show
signific
effect
mean
time
onset
pain
relief
suggest
possibl
agerel
differ
clinic
effect
steroid
younger
patient
find
difficult
estim
pain
relief
begin
howev
wide
confid
interv
could
due
small
sampl
size
paediatr
popul
point
need
taken
account
evalu
avail
data
concomit
therapi
role
aetiolog
case
corticosteroid
given
togeth
antibiot
least
first
day
treatment
paracetamol
ibuprofen
antibiot
albeit
slight
effect
pain
elimin
bacteria
consequ
reduc
inflamm
may
difficult
identifi
independ
effect
corticosteroid
sore
throat
symptom
furthermor
trial
small
group
children
neg
latex
agglutin
test
pyogen
treat
dexamethason
placebo
bulloch
et
al
find
statist
signific
differ
two
group
mean
time
clinic
signific
pain
relief
respect
h
effect
size
h
confid
interv
ci
h
time
complet
pain
relief
vs
h
effect
size
h
ci
h
term
aetiolog
studi
differenti
pyogen
posit
neg
case
found
corticosteroid
effect
former
although
differ
limit
hour
consequ
margin
clinic
import
still
data
concern
pneumonia
given
possibl
posit
role
corticosteroid
lower
respiratori
tract
infect
due
pathogen
may
import
gap
fill
small
sampl
size
avail
studi
prevent
identif
best
type
corticosteroid
dose
regimen
rout
administr
studi
found
singl
corticosteroid
dose
given
time
diagnosi
reduc
pain
advantag
prolong
treatment
author
conclud
singl
dose
may
best
way
use
corticosteroid
ap
howev
studi
use
differ
drug
dexamethason
prednison
betamethason
differ
dose
administ
differ
rout
oral
intramuscularli
risk
advers
event
never
investig
longterm
studi
seem
particularli
import
paediatr
children
suffer
repeat
episod
ap
short
period
administr
corticosteroid
lead
neg
effect
impact
bone
densiti
risk
avascular
necrosi
psychosi
blood
sugar
concentr
mani
potenti
neg
taken
account
furthermor
absenc
detail
longterm
followup
mean
known
whether
corticosteroid
increas
risk
extra
case
streptococc
sore
throat
consequ
immunosuppress
activ
suggest
case
streptococc
pneumonia
final
publish
studi
effect
corticosteroid
administr
develop
acut
rheumat
fever
basi
conclud
avail
data
support
use
corticosteroid
patient
ap
everyday
clinic
practic
episod
ap
treat
antibiot
despit
unknown
aetiolog
caus
sever
pain
reason
author
suggest
use
singl
dose
system
corticosteroid
hope
rapid
reduct
throat
pain
avoid
need
antibiot
howev
accord
report
offici
guidelin
feel
place
use
corticosteroid
ap
independ
age
patient
aetiolog
diseas
present
posit
effect
modest
justifi
use
drug
particularli
case
repeat
administr
potenti
advers
event
clearli
evalu
main
reason
administ
corticosteroid
reduc
antibiot
administr
think
systemat
use
centor
mcisaac
score
predict
group
streptococc
pharyng
rapid
test
identif
pyogen
antigen
significantli
effect
without
risk
patient
although
antibiot
vaccin
greatli
reduc
morbid
mortal
associ
cap
particularli
industrialis
countri
remain
signific
clinic
problem
children
adult
worldwid
consider
impact
healthcar
cost
addit
therapeut
intervent
therefor
urgent
need
inflammatori
respons
trigger
entri
pathogen
alveolar
space
use
control
elimin
primari
cap
provid
remain
localis
howev
cytokin
respons
unbalanc
excess
amplifi
clinic
cours
worsen
lead
system
effect
consequ
suggest
system
corticosteroid
could
use
adjunct
therapi
order
acceler
resolut
system
pulmonari
inflamm
earli
phase
diseas
sinc
number
studi
publish
howev
prospect
methodolog
appropri
case
studi
randomis
doubleblind
placebocontrol
moreov
even
highqual
studi
characteris
consider
heterogen
popul
aetiolog
cap
sever
diseas
choic
drug
dose
regimen
rout
administr
outcom
measur
see
tabl
characterist
relev
studi
make
difficult
compar
result
draw
firm
conclus
also
explain
case
studi
report
conflict
result
lead
recent
perform
metaanalysi
conclud
corticosteroid
improv
clinic
outcom
cap
howev
analysi
singl
studi
seem
suggest
sever
diseas
aetiolog
cap
play
role
condit
respons
corticosteroid
import
cap
sever
suggest
data
collect
confalonieri
et
al
mikami
et
al
author
respect
studi
effect
hydrocortison
prednisolon
sever
vital
sign
well
radiolog
laboratori
test
adult
cap
former
includ
sever
cap
case
report
day
corticosteroid
administr
treat
patient
compar
control
subject
signific
improv
pao
fio
chest
radiograph
score
p
signific
reduct
creactiv
protein
level
mod
score
delay
septic
shock
contrari
mikami
et
al
enrol
patient
cap
differ
degre
sever
found
posit
effect
corticosteroid
margin
mild
case
significantli
promin
moder
sever
subgroup
regard
aetiolog
confalonieri
et
al
marik
et
al
found
use
hydrocortison
reduc
need
mechan
ventil
adult
cap
well
length
stay
intens
care
unit
icu
wherea
van
woensel
et
al
found
corticosteroid
treatment
neg
children
last
group
enrol
children
age
year
mechan
ventil
respiratori
syncyti
viru
lower
respiratori
tract
infect
children
prestratifi
sever
oxygen
abnorm
admiss
superior
approach
use
subgroup
patient
mild
oxygen
abnorm
arteri
partial
pressur
oxygenfract
inspir
oxygen
concentr
pao
fio
mmhg
andor
mean
arteri
pressur
cmh
noninferior
approach
sever
oxygen
abnorm
pao
fio
mmhg
mean
arteri
pressur
cmh
primari
outcom
durat
mechan
ventil
subgroup
mild
oxygen
abnorm
includ
patient
receiv
dexamethason
mgkgday
h
placebo
subgroup
sever
oxygen
abnorm
includ
patient
receiv
dexamethason
placebo
result
show
evid
benefici
effect
dexamethason
repeatedli
demonstr
corticosteroid
effect
children
respiratori
syncyti
viru
infect
hand
snijder
et
al
found
prednisolon
margin
neg
effect
adult
enrol
patient
sever
cap
found
rate
clinic
cure
day
prednisolon
group
placebo
group
respect
patient
prednisolon
experienc
rapid
defervesc
faster
decreas
serum
creactiv
protein
level
receiv
placebo
subanalysi
patient
sever
cap
reveal
differ
clinic
outcom
late
failur
h
admiss
frequent
prednisolon
group
vs
patient
vs
despit
conflict
result
expert
think
administr
corticosteroid
may
favour
rapid
resolut
diseas
symptom
reduc
rate
relaps
mild
case
relev
effect
drug
occur
sever
case
reduc
hypooxygen
need
mechan
ventil
length
icu
stay
particularli
patient
lack
high
adren
respons
patient
sever
cap
usual
high
serum
cytokin
cortisol
level
respect
express
sever
inflamm
consequ
adren
respons
tri
reduc
damag
caus
inflamm
adren
respons
lack
cap
tend
becom
sever
neg
evolut
remmelt
et
al
measur
cortisol
level
serum
cap
patient
found
adjuv
corticosteroid
administr
associ
signific
decreas
risk
death
icu
admiss
patient
high
cytokin
level
cortisol
level
suggest
measur
cortisol
level
help
identifi
patient
sever
cap
benefit
corticosteroid
treatment
moreov
data
collect
children
support
hypothesi
corticosteroid
may
effect
case
sever
cap
associ
pneumonia
infect
accompani
wheez
lee
et
al
tamura
et
al
retrospect
evalu
effect
prednisolon
methylprednisolon
children
cap
document
pneumonia
infect
whose
clinic
radiograph
find
progress
worsen
despit
theoret
adequ
macrolid
therapi
found
corticosteroid
associ
among
patient
receiv
receiv
corticosteroid
hospitalis
longer
adjust
odd
ratio
ci
moreov
corticosteroid
associ
readmiss
patient
receiv
concomit
therapi
adjust
odd
ratio
ci
case
ap
longterm
data
avail
concern
safeti
toler
addit
corticosteroid
standard
cap
treatment
howev
data
collect
immedi
end
therapi
suggest
associ
signific
advers
event
conclus
even
cap
avail
data
permit
draw
firm
conclus
use
corticosteroid
treatment
diseas
administr
corticosteroid
mild
moder
cap
case
recommend
open
point
use
drug
sever
case
particularli
requir
admiss
icu
howev
studi
need
order
better
defin
characterist
patient
pathogen
addit
realli
need
type
drug
dosag
prescrib
well
precis
discov
real
safeti
toler
treatment
although
incid
aom
significantli
reduc
widespread
use
vaccin
possibl
caus
pathogen
diseas
remain
one
common
infecti
diseas
childhood
almost
children
experi
least
one
episod
first
year
life
case
aom
preced
upper
respiratori
tract
viral
infect
consid
bacteri
diseas
bacteri
pathogen
mainli
pneumonia
untyp
haemophilu
influenza
found
middl
ear
fluid
acut
episod
given
aetiolog
effect
primari
treatment
aom
antibiot
administr
howev
one
consequ
antibiot
therapi
bacteri
death
releas
inflammatori
bacteri
product
ie
lipopolysaccharid
peptidoglycan
dna
exacerb
prolong
inflamm
middl
ear
lead
otiti
media
effus
ome
episod
aom
shown
higher
level
inflammatori
mediat
correl
neg
outcom
antibiot
reduc
cytokin
level
middl
ear
effus
howev
antiinflammatori
properti
system
corticosteroid
may
reduc
cytokin
product
limit
risk
neg
evolut
experiment
anim
purul
aom
found
posit
effect
reduc
earli
vascular
leakag
leukocyt
infiltr
lower
concentr
leukotrien
middl
ear
fluid
howev
one
studi
evalu
impact
system
corticosteroid
cours
aom
carri
year
ago
chonmaitre
et
al
enrol
children
aom
age
month
year
randomis
doubleblind
placebocontrol
trial
given
one
intramuscular
dose
ceftriaxon
assign
receiv
prednisolon
mgkgday
placebo
day
main
outcom
measur
rate
treatment
failur
first
two
week
durat
middl
ear
effus
rate
aom
recurr
none
significantli
chang
treatment
clinic
margin
advantag
system
corticosteroid
treatment
higher
frequenc
temporarili
normalis
tympanometr
find
day
howev
author
admit
result
debat
rate
failur
receiv
antibiot
alon
group
low
thu
leav
less
room
show
efficaci
adjunct
drug
higher
proport
temporari
improv
tympanometr
find
may
reflect
posit
effect
corticosteroid
eustachian
tube
function
might
led
reduc
risk
ome
longer
administr
unfortun
highqual
studi
carri
effect
corticosteroid
aom
still
undefin
acut
pharyng
ap
communityacquir
pneumonia
cap
acut
otiti
media
aom
common
infecti
diseas
often
treat
system
corticosteroid
least
countri
although
codifi
offici
guidelin
review
show
evid
effect
system
corticosteroid
diseas
ap
posit
effect
demonstr
studi
ie
rapid
reduct
throat
pain
possibl
avoid
need
antibiot
modest
justifi
use
drug
particularli
case
repeat
administr
potenti
advers
event
clearli
evalu
cap
administr
corticosteroid
mild
moder
case
recommend
open
point
remain
use
drug
except
situat
like
sever
case
requir
admiss
intens
care
unit
icu
aom
highqual
studi
carri
mean
current
indic
univers
use
system
corticosteroid
review
diseas
although
avail
data
suggest
use
may
discuss
sever
case
cap
use
corticosteroid
treat
aom
seem
justifi
mani
case
spontan
resolv
without
sequela
case
otiti
media
effus
ome
seriou
clinic
problem
